Why is the FDA and the CDC dragging their feet on off-label use when clinical trials in four countries, and patient usage in Kansas, already shows efficacy in treatment of COVID-19?
Why is the FDA and the CDC dragging their feet on off-label use when clinical trials in four countries, and patient usage in Kansas, already shows efficacy in treatment of COVID-19?